➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Johnson and Johnson
Mallinckrodt
Colorcon
Moodys

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Patent: 9,814,714

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,814,714
Title:Kinase modulation, and indications therefor
Abstract: The present disclosure provides methods of treating a subject suffering from or at risk of a BRAF V600 mutation or BRAF fusion mutation related disease or condition, without activating the MAPK pathway or inducing expression of MAPK pathway genes in cells harboring wild-type BRAF.
Inventor(s): Ibrahim; Prabha N. (Mountain View, CA), Zhang; Chao (Moraga, CA), Spevak; Wayne (Berkeley, CA), Zhang; Jiazhong (Foster City, CA), Wu; Guoxian (Palo Alto, CA), Lin; Jack (Hercules, CA), Cho; Hanna (Oakland, CA), Nespi; Marika (Berkeley, CA), Shi; Songyuan (Fremont, CA), Ewing; Todd (Walnut Creek, CA), Zhang; Ying (Fremont, CA), Bollag; Gideon (Orinda, CA)
Assignee: Plexxikon Inc. (Berkeley, CA)
Application Number:15/160,729
Patent Claims:see list of patent claims

Details for Patent 9,814,714

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial Plexxikon Inc. (Berkeley, CA) 2035-05-22 RX search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial Plexxikon Inc. (Berkeley, CA) 2035-05-22 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial Plexxikon Inc. (Berkeley, CA) 2035-05-22 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Baxter
Merck
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.